Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis
This study found that the levonorgestrel-releasing intrauterine system (LNG-IUS) significantly decreased expression of nerve growth factor (NGF), NGFR p75, and TrkA in endometrial and myometrial tissues of adenomyosis patients compared to untreated patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (27)
- Adenomyosis: current perspectives via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Correlations between extent and spread of adenomyosis and clinical symptoms via openalex
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging via openalex
- Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis via openalex
- Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids via openalex
- High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis via openalex
- Medical and surgical management of adenomyosis via openalex
- Pathophysiology of adenomyosis via openalex
- The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- W2059524959 via openalex
- W2062227896 via openalex
- W2042451882 via openalex
- W2038354928 via openalex
- W2026781892 via openalex
- W2090571181 via openalex
- W2024418590 via openalex
- W1992638684 via openalex
- W1971927237 via openalex
- W2119767373 via openalex
- W2126884778 via openalex
- W2137979524 via openalex
- W2141232083 via openalex
- W1965039757 via openalex
- W2157162135 via openalex
- W2329132278 via openalex
Cited by (21)
- Clinical Efficacy of Levonorgestrel Releasing Intrauterine System versus Dienogest for Women having Symptomatic Adenomyosis 2023
- Impact of Adenomyosis on Infertile Patients-Therapy Options and Reproductive Outcomes 2022
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis 2021
- The Pathogenesis of Adenomyosis 2021
- IMMUNOLOGICAL FACTORS IN THE DIAGNOSIS OF THE SEVERITY OF THE CLINICAL COURSE OF ADENOMYOSIS 2020
- The Role of Proinflamatory Cytokines in the Development of Clinical Picture of Myoma and Adenomyosis 2020
- Faculty Opinions recommendation of The impact of adenomyosis on women's fertility. 2019
- Partners in Crime: NGF and BDNF in Visceral Dysfunction 2019
- [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis] 2019
- Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study 2018
- Minimally invasive treatment of adenomyosis 2018
- Expression of Nerve Injury-Induced Protein1 (Ninj1) in Endometriosis 2018
- Expression of Nerve Injury-Induced Protein1 (Ninj1) in Endometriosis 2018
- Ginsenoside Rg3 Decreases Fibrotic and Invasive Nature of Endometriosis by Modulating miRNA-27b: In Vitro and In Vivo Studies 2017
- Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis 2016
- The Endometrium in Adenomyosis 2015
- Peripheral changes in endometriosis-associated pain 2014
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β 2013
- The endometrium in adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:04.945943+00:00